AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06696989 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core stability exercises
Description: This group participants will receive core stability exercises, and the total treatment session will also be 60 minutes. The routine physical therapy includes breathing, stretching, joint rotations, ROM's, and frequent periods of rest in between the treatment sessions. To begin the intervention the investigator will perform core stability exercises for 40 minutes in total with rest intervals between each exercise and initially performing 5 repetitions and then gradually progressing to 10 and then 15 repetitions, respectively after 2 weeks.
Study NCT06696924 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reciprocal inhibition
Description: First Subjects will start doing baseline warmup exercises which are mentioned then they will perform reciprocal inhibition of the serratus muscle in supine or side-lying. After identifying the antagonist muscles of the serratus anterior, which are typically the rhomboids or the middle and lower trapezius. Athletes will perform a gentle contraction of the antagonist's muscles by retracting or squeezing their shoulder blades together. While the antagonist muscles are contracting, we will ask the athlete to simultaneously relax and lengthen the serratus anterior muscle. The patient can achieve this by protracting or pushing their shoulder blades forward and away from each other.
Study NCT06696924 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Static stretching
Description: Subjects will perform 2 stretches~1. Standing Wall Stretch: Stand facing a wall with your feet about hip-width apart. Place their palms on the wall at shoulder height, slightly wider than shoulder-width apart. will Lean their body forward, keeping their arms straight, until feel a stretch in their serratus anterior. Hold the stretch for 15 to 30 seconds, then slowly release. Instead of using a wall or object, the athlete will use their opposite hand to hold the stretched arm in position.~2. Seated Cross-Body Stretch: Sit on the edge of a chair or bench. Cross one arm over your chest, placing your hand on the opposite shoulder. The athlete will use the other hand to gently pull the crossed arm closer to your body, feeling a stretch in the serratus anterior. Hold the stretch for 15 to 30 seconds or more, and then switch sides and repeat.
Study NCT06697067 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: modified smead jones
Description: interrupted suture technique
Study NCT06697067 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional comtinuous suture techniques
Description: continuous suture technique
Study NCT06697119 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fecal Microbial Transplantation
Description: Fecal suspension is delivered to duodenal 3rd portion via esophagogastroduodenoscopy
Study NCT06696950 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mutimodal gait training includes unilateral step training, inclined treadmill training, over ground training with rhythmic auditory stimulation
Description: Unilateral step training, inclined treadmill training, over ground training, repetitive isochronous pulses via metronome
Study NCT06696950 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multimodal gait training
Description: Unilateral step training, inclined treadmill training, over ground training,
Study NCT06696872 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: core exercises
Description: The core muscle strength training program were lasted for 8 weeks and comprised of 3 training sessions per week, with a total of 24 sessions. Each session were lasted for 30 to 45 minutes, starting with a brief warm-up exercise program consisting of low-intensity core strength exercises to prepare the neuromuscular system for the training loads and ending with a cool-down program
Study NCT06696872 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation
Description: The hold-relax proprioceptive neuromuscular facilitation stretching protocol consisted of passively moving the dominant leg into a position where the subjects felt mild discomfort and holding that position for 30 seconds. Subjects were then asked to isometrically contract the stretched muscle for 10 seconds; this were followed by muscle relaxation in the same posi¬tion for 30 seconds, before being stretched to a new point of mild discomfort. The leg were then released
Study NCT06484764 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: CT-fluoroscopy guided robot-assisted biopsy of thoracic and abdominal lesions
Description: During the procedure, the participant first undergoes a CT scan the radiologist plans the needle trajectory based on the registered preoperative CECT (contrast-enhanced computed tomography~) and intraoperative CT. After the participant is manually sterilised and given local anaesthesia, the radiologist will remotely control the robot to finish the needle insertion process under the CT-fluoroscopy guidance and simultaneously adjust the angular needle if necessary. The radiologist confirms whether the needle has reached the target area by CT-fluoroscopy image.
Study NCT06484764 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Freehand CT-guided percutaneous needle biopsy of thoracic and abdominal lesions
Description: Radiologists following the current clinical practice guidance to finish the freehand biopsy procedure under the CT guidance.
Study NCT05386719 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Prescreening
Description: Eligible patients (history of early stage breast cancer and at least 3 months from completion of local and systemic therapy at Johns Hopkins, reads and speaks English) complete survey for demographics, smoking status \& questions about cardiovascular disease.
Study NCT05386719 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Screening and Enrollment
Description: Consent
Study NCT05386719 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Baseline
Description: Behavioral Battery and Patient Reported Outcome Quality of Life questionnaires (EORTC QLQ-C30 and QLQ-BR23) Labs (Hba1c + lipid panel if not done within 12 months or if abnormal within 1 year) Abstract vitals from chart review
Study NCT05386719 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Interpret BMI
Description: Refer to Healthful Eating, Activity and Weight Program (HEAWP) if BMI ≥25 and not already on lifestyle intervention
Study NCT05386719 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Interpret HbA1c
Description: HbA1c results categorized as follows:~HbA1c \<5.7%; HbA1c 5.7-6.4%; HbA1c 6.5%+; or Known diabetic on medication
Study NCT05386719 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Interpret lipid panel and assess other risk factors
Description: Based on above categories:~HbA1c \<5.7%: Any of these cardiovascular disease risk factors: current/former tobacco use, total cholesterol >200, family history of Coronary Artery Disease/Heart Attack in first degree family \<55 year old male or \<65 year old female, systolic blood pressure >130 HbA1c 5.7-6.4%: Refer to Primary Care Provider and consider Healthful Eating, Activity and Weight Program (HEAWP) HbA1c 6.5%+: Refer to Endocrinology if HbA1c ≥8% Known diabetic on medication: Refer to Endocrinology if HbA1c ≥7%
Study NCT05386719 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Assess 10 year risk of cardiovascular event
Description: If risk factors are present - refer to Cardiovascular Disease Prevention Program
Study NCT05386719 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Recommendations
Description: Provide individual patient handout based on all above interventions
Study NCT05386719 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Follow-Up
Description: 6 and 12 month labs (if prior abnormal) and Patient Reported Outcome questionnaires
Study NCT05881785 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GR1501 low dose
Description: 3×low dose GR1501 every 2 weeks,then low dose GR1501 monthly
Study NCT05881785 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GR1501 high dose
Description: 3×high dose GR1501 every 2 weeks,then high dose GR1501 monthly
Study NCT05881785 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: * Core treatment period:placebo~* Maintenance treatment period: GR1501 injection
Study NCT06003101 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bone marrow aspirate concentrate (BMAC)
Description: Bone marrow aspiration from the body of the ilium will be performed through one of the arthroscopic portals.
Study NCT06003101 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Standard of care hip arthroscopy without bone marrow aspiration will be performed in these patients.
Study NCT04912206 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Point-of-Care Ultrasound
Description: Abdominal clinician-performed Ultrasound
Study NCT05341492 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: EGFR/B7H3 CAR-T
Description: 2 × 10\^6/kg CAR-T cells,For subjects with body weight greater than 60 kg, the number of cells can only be calculated according to 60 kg of body weight.
Study NCT06158347 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: hyperbaric oxygen chamber
Description: Hyperbaric oxygen therapy allows patients to breathe 100% oxygen through an O2 Fresh M50 (HBOT Medical, Wonju, South Korea) chamber. Upon entering the chamber, oxygen is supplied by gradually increasing the barometric pressure from normal pressure to 1.5 atmospheres absolute (ATA).
Study NCT06116110 — intervention group
Intervention type: OTHER
Intervention: Long-term Follow-Up
Description: No intervention
Study NCT05243550 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UGN-102
Description: UGN-102 consists of mitomycin and sterile hydrogel (a proprietary thermally responsive gel) that is used to reconstitute mitomycin before instillation. The reverse thermal properties of UGN-102 allow for local administration of mitomycin as a liquid under chilled conditions, with subsequent conversion to a semi-solid gel depot following instillation into the bladder.
Study NCT06062030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWJ1609
Description: Drug of test group
Study NCT06062030 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DWC202304
Description: Drug of control group
Study NCT05413304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pre-operative abemaciclib
Description: pre-operatively for 4.5 days; 200mg twice daily (9 total doses)
Study NCT05272774 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FOREST+
Description: The intervention will be delivered as an online stress recovery intervention consisting of six weekly modules. Modules include an introduction, psychological detachment, distancing, mastery, control, and keeping the change alive. These modules have been chosen after considering the themes that could be most useful for healthcare workers under high stress. Each module consists of a psychoeducational and an exercise component.
Study NCT05413304 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Device for Cerebral Fluid Dialysate Collection
Description: post-resection or post-biopsy continuous intracerebral microdialysis sampling for 48-hours to assess CNS drug entry and targeted inhibition with abemaciclib
Study NCT05413304 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ashion Analytics GEM ExTra
Description: resection/biopsy genomic sampling of tumor tissue and blood to identify therapeutic targets
Study NCT05413304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: abemaciclib + temozolomide
Description: abemaciclib 150mg po BID and temozolomide 200mg/m2 po daily x 5 days in 28 day cycles (temozolomide 150mg/m2 po daily x 5 days for cycle 1)
Study NCT04393181 — intervention group
Intervention type: PROCEDURE
Intervention: Heart transplantation 1
Description: Heart transplantation will be performed according to local routines. Recipients will be transplanted with a donor heart with left ventricular dysfunction, defined as an ejection fraction less than 50% or regional hypokinesia.
Study NCT04393181 — intervention group
Intervention type: PROCEDURE
Intervention: Heart transplantation 2
Description: Heart transplantation will be performed according to local routines. Recipients will be transplanted with a donor heart with normal function, according to the recommendations from The International Society for Heart and Lung Transplantation (ISHLT).
Study NCT06442917 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breathing Exercise
Description: 32 the Pregnant Identifying Characteristics Form, the Short Version of the Self-Efficacy Scale in Childbirth was completed before the pregnancy intervention and the VAS was measured. Breathing exercise training and application were carried out during the latent phase process. In this training, the importance of proper breathing was explained and diaphragmatic breathing application was made.~During the active phase process (4-7 cm), the Innatal Period Evaluation Form was filled out and the VAS was measured, and diaphragmatic breathing exercise was performed every 30 minutes from the beginning of contraction until the end of contraction. During the transition phase (8-10 cm), the Innatal Period Evaluation Form, the Short Version of the Self-Efficacy Scale in Childbirth were filled out and the VAS was measured, and diaphragmatic breathing exercise was performed once every 15 minutes from the beginning of contraction to the end of contraction.
Study NCT04955795 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Alcohol Brief Intervention (BI)
Description: The BI we will use was based on CETA's substance use module and was designed for one-on-one delivery. It is comprised of 6 elements (i.e. assessment, understanding impacts, exploring change, goal setting, identifying the reasons, and skill building) including a 2-week alcohol timeline follow back assessment, which is completed by the therapist. BI will be provided by a trained research assistant who has completed consent, enrollment, and randomized procedures with the client.
Study NCT06442917 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Affirmation Method
Description: 32 pregnant women who were admitted to the hospital for childbirth and were in the latent phase (0-3 cm) filled out the pre-intervention Pregnant Identifying Characteristics Form, the Short Version of the Self-Efficacy Scale in Childbirth, and the VAS was measured. During the latent phase, affirmation phrases were shown to the pregnant women and the application was explained. During the active phase process (4-7 cm), the Innatal Period Evaluation Form was filled out and the VAS was measured, and the affirmation phrases were repeated and used by the researcher every 30 minutes from the beginning of the contraction until the end of the contraction.~During the transition phase (8-10 cm), the Innatal Period Evaluation Form, the Short Version of the Self-Efficacy Scale in Childbirth were filled out and the VAS was measured, and affirmation sentences and support sentences were said every 15 minutes from the beginning of the contraction to the end of the contraction.
Study NCT06442917 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breathing Exercise and Affirmation Method
Description: During the latent phase, affirmation phrases were shown to the pregnant women and the application was explained and the application was made with breathing exercise training. In this training, the importance of proper breathing was explained and diaphragmatic breathing application was made. During the active phase process (4-7 cm), the Congenital Period Evaluation Form was filled out and the VAS was measured, and diaphragmatic breathing exercise was performed once every 30 minutes from the beginning of contraction to the end of contraction, and the affirmation phrases were repeated and used by the researcher
Study NCT04955795 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Alcohol Brief Intervention (BI)
Description: The BI we will use was based on CETA's substance use module and was designed for one-on-one delivery. It is comprised of 6 elements (i.e. assessment, understanding impacts, exploring change, goal setting, identifying the reasons, and skill building) including a 2-week alcohol timeline follow back assessment, which is completed by the therapist. BI will be provided by a trained research assistant who has completed consent, enrollment, and randomized procedures with the client.
Study NCT04955795 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Common Elements Treatment Approach (CETA) via Telemedicine
Description: CETA consists of nine key elements (i.e. engagement and education; safety assessment and planning; psychoeducation/introduction; substance use reduction; behavioral activation; cognitive coping/restructuring; relaxation; exposure; and problem solving) that address common mental health problems such as trauma, PTSD, depression, and anxiety. Participants randomized to CETA will be assigned to a CETA provider (clinical psychology or social work graduate student or master's degree substance abuse counselor). Enrolled participants will be discussed at weekly supervision meetings. An individualized treatment plan will be designed for each participant including type and order of CETA modules. The counselor will contact the participant by phone to schedule CETA sessions and follow up any missed appointments. Counselors, who will also be given a unique ID# for documentation and analysis, will carry 3-10 active CETA cases at a time depending on their experience level.
Study NCT05922423 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MBSR
Description: Week 1: Introduce mindfulness theory knowledge to participants and guide them to engage in mindfulness breathing training; Week 2: Sitting meditation, explaining the essence of meditation and practicing with music; Week 3: Explain the connotation of walking meditation, inform the participants of precautions, and guide them to practice; Week 4: Explain the connotation and requirements of body scanning, guide participants in practice; Week 5: Introduce the connotation of hatha yoga and guide participants to practice; Week 6: Explain the meaning of mindfulness sounds and thoughts, guide participants to practice; Week 7: Explain the characteristics of non selective perception, combined with music practice; Week 8: Emphasize mindfulness to promote health, encourage participants to practice internalization, and develop into their own patterns.
Study NCT05200390 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitor
Description: FreeStyle Libre 2 system
Study NCT05240859 — intervention group
Intervention type: DRUG
Intervention: Geleli
Description: Adalimumab Biosimilar
Study NCT05709548 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Indocyanine green
Description: Subjects with a diagnosis of acute cholecystitis who undergo urgent laparoscopic cholecystectomy with the preoperative administration of indocyanine green (between 1-2 hours prior to surgery).
Study NCT05064514 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter Tricuspid Valved Stent Graft
Description: All participants meeting the inclusion and none of the exclusion criteria will be enrolled. A custom-made Transcatheter Tricuspid Valved Stent Graft based on CT to define anatomic dimensions will be made. The system consists of a custom-made valved stent graft delivery system, a custom-made valved stent graft bioprosthesis and a loading system. The bioprosthesis is self-expanding and consists of a stent graft spanning from the inferior vena cava to the superior vena cava and a lateral bicuspid valve element made of thin porcine pericardial leaflets requiring a low closing pressure, and Nitinol support structures. The participants will undergo a minimally invasive, catheter-based procedure to implant the bioprosthesis which is delivered through a 24 French delivery system via transfemoral access. The device can be repositioned and is retrievable.
Study NCT06439953 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate solution
Description: Evaluating the prophylactic use of Irrisept irrigation alone
Study NCT06439953 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vancomycin
Description: Evaluating the use of versus vancomycin-saline irrigation with or without topical vancomycin
Study NCT04430517 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside
Description: Participants will take 4 pills every day, each containing 250 mg NR (NIAGEN® by Chromadex; www.chromadex.com), via the oral route, for 12 weeks.
Study NCT06334497 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letermovir
Description: 480mg (2X240mg- tablets) of Letermovir given orally once a day until the treatment success or the treatment failure, up to 12 weeks. In case of co-administration with cyclosporine A, the dosage of Letermovir will be reduced.
Study NCT06334497 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Valganciclovir
Description: Valganciclovir 900 mg (2X450 mg-tablets) twice a day until the treatment success or the treatment failure, up to 12 weeks. In case of impaired renal function, the dosage of valganciclovir will be reduced.
Study NCT06334497 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valganciclovir
Description: Valganciclovir 900 mg (2X450 mg-tablets) twice a day until the treatment success or the treatment failure, up to 12 weeks. In case of impaired renal function, the dosage of valganciclovir will be reduced.
Study NCT04011787 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: bolus NGT feeding
Description: Participants randomised to bolus NGT feeding will receive this for 7 days at mealtimes
Study NCT04011787 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Continuous NGT feeding
Description: Participants randomised to bolus NGT feeding will receive this continuously for 7 days as per hospital protocol
Study NCT04011787 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Glucose Monitoring
Description: Both participant groups will have continuous glucose monitoring performed for 5 days while in the study